Toho Zinc Valuation
Is T62 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of T62 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: T62 (€4.84) is trading above our estimate of fair value (€1.49)
Significantly Below Fair Value: T62 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for T62?
Key metric: As T62 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is T62's PS Ratio? | |
|---|---|
| PS Ratio | 0.08x |
| Sales | JP¥132.37b |
| Market Cap | JP¥10.71b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.6x |
| Enterprise Value/EBITDA | 12.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does T62's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.6x | ||
BNN BRAIN Biotech | 1.2x | 8.5% | €71.4m |
2HRA H&R GmbH KGaA | 0.09x | 3.0% | €129.2m |
NTG Nabaltec | 0.6x | 5.0% | €123.2m |
IBU IBU-tec advanced materials | 0.6x | 19.2% | €27.8m |
T62 Toho Zinc | 0.08x | 0.4% | €10.7b |
Price-To-Sales vs Peers: T62 is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.6x).
Price to Sales Ratio vs Industry
How does T62's PS Ratio compare vs other companies in the European Metals and Mining Industry?
Price-To-Sales vs Industry: T62 is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Metals and Mining industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is T62's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.08x |
| Fair PS Ratio | 0.1x |
Price-To-Sales vs Fair Ratio: T62 is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Arkema
€5.7b
Manufactures and sells specialty chemicals and advanced materials worldwide.
V1S
€74.85
7D
0.4%
1Y
-19.9%
Minerals Technologies
US$2.6b
Develops, produces, and markets various mineral, mineral-based, and related systems and services.
MNK
US$74.50
7D
1.4%
1Y
33.0%
Cabka
€60.3m
Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.
7GW
€2.38
7D
-7.8%
1Y
-61.1%